QI Program Supplemental Funding Act of 2008
Latest Action
Became Public Law No: 110-379.
Official Summary
(This measure has not been amended since it was introduced. The summary of that version is repeated here.) QI Program Supplemental Funding Act of 2008 - Amends title XIX (Medicaid) of the Social Security Act, as amended by the Medicare Improvements for Patients and Providers Act of 2008, to provide supplemental funding for the qualifying individual (QI) program. Requires a state to have in operation, in mechanized Medicaid claims processing and information retrieval systems, an eligibility determination system which provides for data matching through the Public Assistance Reporting Information System (PARIS) facilitated by the Secretary of Health and Human Services, including matching with medical assistance programs operated by other states. Amends the Federal Food, Drug, and Cosmetic Act to make sponsors of certain antibiotic drugs eligible for a three-year or a five-year market exclusivity if a marketing application is submitted for an antibiotic drug that: (1) was approved by the Secretary of Health and Human Services before November 21, 1997; or (2) was the subject of one or more applications received by the Secretary before November 21, 1997, none of which was approved. Authorizes the use of Medicaid integrity program funds for transportation and travel expenses for attendees at education, training, or consultative activities. Increases FY2014 funding for the Medicare Improvement Fund.
GovScope Watchdog™
AI Government Intelligence™The QI Program Supplemental Funding Act of 2008 amends Medicaid provisions to provide additional funding for the qualifying individual program. It requires states to implement eligibility determination systems with data matching through the Public Assistance Reporting Information System (PARIS). The bill also amends drug exclusivity rules for certain antibiotics and authorizes Medicaid integrity program funds to cover travel expenses for training activities. Additionally, it increases funding for the Medicare Improvement Fund for fiscal year 2014.
This bill provides supplemental funding and system requirements for Medicaid programs, adjusts drug market exclusivity rules, and increases Medicare Improvement Fund resources, impacting health program administration and funding.
- Provides supplemental funding for the qualifying individual (QI) Medicaid program.
- Requires states to use mechanized eligibility systems with data matching via PARIS.
- Amends drug exclusivity provisions for certain antibiotic drugs approved or applied for before November 21, 1997.
States administering Medicaid programs, sponsors of certain antibiotic drugs, Medicaid program participants, and attendees of Medicaid-related education and training activities may benefit from the provisions of this bill.
Implementation of mechanized eligibility systems with data matching may require technical and administrative resources. Changes to drug exclusivity could affect market competition. The bill increases funding allocations, which may have budgetary implications. Full bill text is not provided, limiting detailed assessment.
This health-related Senate bill from the 110th Congress has passed and become law as Public Law 110-379. It reflects legislative action to amend Medicaid and related health program funding and administration.
Hidden impact flags detected: 2
GovScope reviewed 11 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
The bill’s requirements for data matching and system upgrades could improve eligibility accuracy but may also increase administrative complexity. Changes to drug exclusivity could influence pharmaceutical market dynamics. Increased funding for Medicare Improvement Fund may affect related health services.
The full bill text is not available, limiting detailed analysis. Citizens may want to review how data matching is implemented to understand privacy safeguards. The impact of drug exclusivity changes on antibiotic availability and competition is not detailed. Monitoring the use of increased funds for Medicaid and Medicare programs could be important.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.